Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Partha Kar

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
Diabetes, Obesity & Metabolism|June 1, 2026
Glycaemic Control by Sociodemographic Factors in Adults With Type 1 Diabetes in England: Trends From 2007-2008 to 2023-2024Muhammad Saleem Khan, Jonathan Valabhji, Naveed Sattar, et al.
European Journal of Endocrinology|June 9, 2020
ENDOCRINOLOGY IN THE TIME OF COVID-19: Remodelling diabetes services and emerging innovationDeborah J Wake, Fraser W Gibb, Partha Kar, et al.
BMC Medical Education|July 28, 2010
Protocol for a national audit on self-reported confidence levels, training requirements and current practice among trainee doctors in the UK: the Trainees Own Perception of Delivery of Care in Diabetes (TOPDOC) StudyJyothis T George, David J McGrane, David Warriner, et al.
The Lancet. Diabetes & Endocrinology|August 18, 2020
Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population studyEmma Barron, Chirag Bakhai, Partha Kar, et al.
The Lancet. Diabetes & Endocrinology|August 18, 2020
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort studyNaomi Holman, Peter Knighton, Partha Kar, et al.
BMC Medical Education|September 18, 2014
Differences in level of confidence in diabetes care between different groups of trainees: the TOPDOC diabetes studyChristopher J Smith, Jyothis T George, David Warriner, et al.
The Lancet. Diabetes & Endocrinology|April 2, 2021
Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in EnglandKamlesh Khunti, Peter Knighton, Francesco Zaccardi, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 6, 2026
From language matters to stigma-free communication in diabetes: Evolution, challenges, and next stepsElizabeth Holmes-Truscott, Emmanuel Ekpor, Eloise Litterbach, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 13, 2026
Implementing SGLT2 Inhibitor Therapy in Line with the New NICE Guidelines for Type 2 Diabetes ManagementPhilip Newland-Jones, Partha Kar, Beth Kelly, et al.
The Health Service Journal|June 25, 2014
NHS England chief executive: welcome back, Simon. Here's your to-do listJohn Appleby, Anita Charles, Alan Maynard, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
Diabetes, Obesity & Metabolism|June 1, 2026
Glycaemic Control by Sociodemographic Factors in Adults With Type 1 Diabetes in England: Trends From 2007-2008 to 2023-2024Muhammad Saleem Khan, Jonathan Valabhji, Naveed Sattar, et al.
European Journal of Endocrinology|June 9, 2020
ENDOCRINOLOGY IN THE TIME OF COVID-19: Remodelling diabetes services and emerging innovationDeborah J Wake, Fraser W Gibb, Partha Kar, et al.
BMC Medical Education|July 28, 2010
Protocol for a national audit on self-reported confidence levels, training requirements and current practice among trainee doctors in the UK: the Trainees Own Perception of Delivery of Care in Diabetes (TOPDOC) StudyJyothis T George, David J McGrane, David Warriner, et al.
The Lancet. Diabetes & Endocrinology|August 18, 2020
Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population studyEmma Barron, Chirag Bakhai, Partha Kar, et al.
The Lancet. Diabetes & Endocrinology|August 18, 2020
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort studyNaomi Holman, Peter Knighton, Partha Kar, et al.
BMC Medical Education|September 18, 2014
Differences in level of confidence in diabetes care between different groups of trainees: the TOPDOC diabetes studyChristopher J Smith, Jyothis T George, David Warriner, et al.
The Lancet. Diabetes & Endocrinology|April 2, 2021
Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in EnglandKamlesh Khunti, Peter Knighton, Francesco Zaccardi, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 6, 2026
From language matters to stigma-free communication in diabetes: Evolution, challenges, and next stepsElizabeth Holmes-Truscott, Emmanuel Ekpor, Eloise Litterbach, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 13, 2026
Implementing SGLT2 Inhibitor Therapy in Line with the New NICE Guidelines for Type 2 Diabetes ManagementPhilip Newland-Jones, Partha Kar, Beth Kelly, et al.
The Health Service Journal|June 25, 2014
NHS England chief executive: welcome back, Simon. Here's your to-do listJohn Appleby, Anita Charles, Alan Maynard, et al.
Pageof 13